Recent

% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • telsarowe telsarowe Jan 3, 2013 11:27 AM Flag

    Putting the "Fool" in Motley Fool

    "Aside from that, aren't these risks common to all biotechs with product in development and therefore kind of a given for this stock?" .........ummmm no. quality biotech management doesnt dilute their shareholders to the point of irrelevancy and have to go beg its feeble incoherent founder for repeated life lines after tgeyve spent everything on S Class leases, wine, perpetual catering and sporting events.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ".........ummmm no. quality biotech management doesnt dilute their shareholders to the point of irrelevancy and have to go beg its feeble incoherent founder for repeated life lines after tgeyve spent everything on S Class leases, wine, perpetual catering and sporting events."

      You knew when the dilutions were coming... shame on you for not getting out when you should have. Smart investors have made a killing on mnkd. both short and long and quite frankly there is nothing wrong at all with either strategy. I am here to make money not join a bandwagon.

      So let me give you a piece of advice. Load the boat up on jan 14 call options.... watch that triple over the next 3-4 months, then swing trade the massive volatile swings that will come in May once we phase 3 data and all of the #$%$ buy and sell in massive panic/celebratory conundrums. Once that settles down over the course of 3-4 weeks... go long again via shares and hold for a 30-50% gain over 2-3 months and get out the end of August because dilution is coming again and short the hell out of it. After dilution, load up on calls and sit in nervous anxiety on adcom day and approval day and rejoice in the fact that you listened bbradfor's advice and are sitting on a 1000% gain in just one stock.

      Sentiment: Strong Buy

 
MNKD
4.29-0.17(-3.81%)Jul 31 4:00 PMEDT